175 results
8-K
CHRS
Coherus Biosciences Inc
4 Jun 24
Submission of Matters to a Vote of Security Holders
4:05pm
stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
) a report and opinion of Borrower's independent certified public accounting firm of recognized national standing (which report and opinion shall … Act of 2002 requiring an attestation report of such independent certified public accounting firm, an attestation report of such independent certified
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
year of the Seller and its Subsidiaries, including the notes thereto, audited by independent public accountants of recognized national standing … or subject to a bona fide dispute, (ii) obligations to pay for services provided by employees and individual independent contractors in the ordinary course
DEFA14A
CHRS
Coherus Biosciences Inc
15 Apr 24
Additional proxy soliciting materials
5:10pm
) Kimberly J. Tzoumakas 2. To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as our independent registered
S-8
EX-23.2
4tpxrdsz
28 Mar 24
Registration of securities for employees
4:04pm
S-8
3y0iv3w0up3tv2oax
28 Mar 24
Registration of securities for employees
4:04pm
8-K
EX-2.1
w9z9kej7m0g0gg
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
lbs5qo
9 Jan 24
Results of Operations and Financial Condition
9:41pm
8-K/A
EX-99.1
umrvt21utjuh wfjh
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-23.1
19yr ok5dg
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am